IP Library Granted Patent US 9,988,614
Granted Patent B1
US 9,988,614 · App. 15/337,597 · Granted Jun 5, 2018

High fidelity BbsI

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,614
App. No.
15/337,597
Granted
Jun 5, 2018
Kind
B1
Abstract

A composition comprising a variant BbsI restriction endonuclease having reduced star activity is provided, as well as kits and methods employing the same.

Claims (28)

1. A composition comprising a variant BbsI restriction endonuclease comprising a subunit A and a subunit B, wherein:

the subunit A comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:1, and

the subunit B comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:2, and wherein the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 in the variant BbsI restriction endonuclease is not a Pro.

2. The composition of claim 1 , wherein the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 in the variant BbsI restriction endonuclease is an Ala.

3. The composition of claim 1 , wherein the composition comprises a non-naturally occurring buffering agent.

4. The composition of claim 1 , wherein the composition comprises glycerol.

5. The composition of claim 1 , wherein the composition comprises a fragment of DNA comprising one or more recognition sequences for the variant BbsI restriction endonuclease.

6. The composition of claim 1 , wherein the composition comprises multiple fragments of DNA that each comprises at least one recognition sequence for the variant BbsI restriction endonuclease.

7. The composition of claim 6 , wherein the multiple fragments have compatible overhangs after they are cleavage by the BbsI variant.

8. The composition of claim 1 , wherein the composition further comprises a ligase.

9. A kit comprising:

(a) the composition of claim 1 ; and

(b) a concentrated buffer comprising a non-naturally occurring buffering agent.

10. The kit of claim 9 , wherein the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 in the variant BbsI restriction endonuclease is an Ala.

11. The kit of claim 9 , further comprising:

(c) a ligase.

12. The kit of claim 11 , wherein the ligase is T4 DNA ligase.

13. A method comprising:

combining the composition of claim 1 with a fragment of DNA comprising a recognition sequence for the variant BbsI restriction endonuclease and a buffer to produce a reaction mix; and

incubating the reaction mix to cleave the fragment.

14. The method of claim 13 , wherein the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 in the variant BbsI restriction endonuclease is an Ala.

15. The method of claim 13 , wherein the reaction mix comprises multiple fragments of DNA that each comprises at least one recognition sequence for the variant BbsI restriction endonuclease.

16. The method of claim 14 , wherein at least two of the cleavage products have compatible overhangs.

17. The method of claim 15 , wherein the reaction mix further comprises a ligase, wherein the ligase ligates the compatible overhangs together.

18. The composition of claim 1 , wherein:

subunit A of the variant BbsI restriction endonuclease comprises an amino acid sequence that is identical to SEQ ID NO:1, and

subunit B of the variant BbsI restriction endonuclease comprises an amino acid sequence that is identical to SEQ ID NO:2 with the exception that the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 is not a Pro.

19. The composition of claim 18 , wherein the amino acid at the position corresponding to amino acid 442 of SEQ ID NO:2 in subunit B is an Ala.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: ZHU, ZHENYU; QUIMBY, AINE
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 040520/0597 →